We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit
BLACU

Delisted

BLACU was delisted on the 14th of February, 2025.

Back to rankings

2 hedge funds and large institutions have $40.4K invested in Bellevue Life Sciences Acquisition Corp. Unit in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

5% less capital invested

Capital invested by funds: $42.5K → $40.4K (-$2.12K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$528
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
$40.3K -$528 -48 -1%
TRCT
2
Tower Research Capital (TRC)
New York
$109 – – –

BLACU Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q2 2024, worth a combined $40.4K — down 5% from $42.5K a quarter earlier.

Fund positioning in BLACU was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Clear Street, cutting an estimated $528.

  • 2 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $40.4K of Bellevue Life Sciences Acquisition Corp. Unit stock for Q2 2024, down 5% quarter-over-quarter.
  • 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q2 2024 and 0 closed out.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q2 2024 was Clear Street, an estimated $528 sold.

Based on aggregated 13F filings for Q2 2024.